key: cord-0829025-b4yxi3k3
authors: Fedewa, Stacey A.; Bandi, Priti; Smith, Robert A.; Silvestri, Gerard A.; Jemal, Ahmedin
title: Lung Cancer Screening Rates During the COVID-19 Pandemic
date: 2021-07-21
journal: Chest
DOI: 10.1016/j.chest.2021.07.030
sha: d2218642957208b9b6cb2aea5f9c4d1fd6edee68
doc_id: 829025
cord_uid: b4yxi3k3

nan

Routine screenings for cancer were paused beginning in March 2020 as the COVID-19 Pandemic emerged in the United States (US). 1 Previous studies reported 80-90% declines in breast, cervical, and colorectal cancer screening volumes in March-April of 2020 before rebounding in the summer of 2021, after clinics resumed routine screening. 2 However, the Pandemic's impact on lung cancer screening (LCS) nationally or by state is not yet known. This is of interest because lung cancer remains the leading cause of cancer death in the US and annual LCS with low dose computed tomography (LDCT) is recommended for a group that is at a high-risk of dying from this disease. 3 The objective in the current study was to examine annual LCS rates before (2019) and during (2020) the Pandemic nationally and according to state.

The numbers of LCS performed in 2019 and 2020 were obtained from the American Table for Wisconsin 11.9 11.7 14.1 11.6 11.4 13.8

Abbreviations: District of Columbia (DC); Confidence Interval (CI); a. The following formulas were used to compute lung cancer screening (LCS) rates and described elsewhere. 5 Population-survey and detailed census data for 2020 have not yet been released so 2019 data were relied upon to compute 2019 and 2020 denominators (ie eligible population). The numerator (number of LDCTs) were based on 2019 and 2020 LCSR data. 95% Confidence intervals were computed with boostrap sampling with 1,000 replicates and accounted for the variation in smoking behavior. 

Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic

Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic

Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement

State Variation in Low-Dose CT Scanning for Lung Cancer Screening in the United States

Trends in Number and Distribution of COVID-19 Hotspot Counties -United States

Eligible adults defined according to 2013 USPSTF criteria-people aged 55-80 years who currently or formerly smoked cigarettes and quit within the past 15 years, with ≥ 30 pack-year smoking history. The number of lung cancer screenings was obtained from the American College of Radiology's Lung Cancer Screening Registry's 2019 and 2020 Reports. 2019 Census estimates were used to compute the population of adults aged 55-80 years. The probability that an adult smoked was computed with 2019 Behavioral Risk Factor Surveillance System and

Confidence intervals were computed with bootstrap sampling with 1000 replicates and accounted for self-reported variation in smoking behavior. Changes in lung cancer screening rates are not shown for Washington DC or Wyoming as the number of lung cancer screenings in 2019 and 2020 were not available due to American College of Radiology's suppression criteria

 25%   UT  RI  HI  VT  MD  CA  TX  AL  MT  MN  MI  NE  NJ  FL  KS  AK  MA  IN  CT  AR  PA  GA  WI  ID  DE  US  AZ  NH  NY  SD  IL  VA  CO  OK  OH  IA  TN  ND  OR  NC  MO  NM  WA  MS  SC  LA  KY  ME  WV   SRR